FOMA

Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity

Retrieved on: 
星期日, 四月 7, 2024
Uric acid, Urinary tract infection, Anaphylaxis, Myocardial infarction, Common, Bronchitis, Patient, Atherosclerosis, FAHA, Cleveland Clinic, Bempedoic acid, Ezetimibe, Therapy, Anemia, Pain, MACE, Sinusitis, ACC, FOMA, FNLA, FACC, Obesity, Cardiovascular disease, Esperion Therapeutics, Abdominal pain, Risk, Gout, Spasm, Woman, American College, Body mass index, ESPR, Back pain, Outcome, ATP, Safety, Fatigue, Arthralgia, ANN, Angioedema, Kidney, Journal, Constipation, University, Adverse event, Pregnancy, CLEAR, Rash, MPH, Rupture, FDA, Molina Healthcare, JACC, Hypersensitivity, Health, Circulatory system, Tablet, CVD, Incidence, Diarrhea, Fetus, Gallstone, Diet, Excipient, Upper respiratory tract infection, Dietary supplement

ANN ARBOR, Mich., April 07, 2024 (GLOBE NEWSWIRE) -- Esperion (Nasdaq: ESPR) today announced the presentation of results from three pre-specified subgroups from CLEAR Outcomes at the 2024 American College of Cardiology’s Annual Scientific Sessions (ACC.24): women, Hispanic/Latinx, and patients with obesity. These results align with the American College of Cardiology’s robust diversity, equity and inclusion programs to drive cultural change across the profession and ensure that the cardiovascular care team is as diverse as the patients they care for and that all patients are represented in cardiovascular research. The data also reinforce the mission of the ACC: transforming cardiovascular care for all.

Key Points: 
  • “Bempedoic acid is the only FDA approved non-statin LDL lowering therapy to demonstrate reductions in MACE in both primary prevention and secondary prevention patient populations.
  • The Hispanic population is the largest ethnic minority in the U.S., yet is a population historically underrepresented in clinical trials.
  • At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases.
  • CLEAR Outcomes is part of the CLEAR clinical research program for NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet.

Found, the Obesity Medicine Association and the Obesity Action Coalition Take Steps to Close the Gap in Obesity Care With Launch of Obesity Medicine Scholarship

Retrieved on: 
星期五, 二月 16, 2024
OMA, Overweight, MD, OAC, Medical director, Obesity, Physician, FOMA, Conference, FACP, Judgement, Certification, Patient, Health equity, Prescription, Obesity medicine, Environment, Travel, Nursing

The program will help ensure there are more obesity medicine experts to provide care to those in need by offering resources to medical providers interested in becoming American Board of Obesity Medicine (ABOM) certified.

Key Points: 
  • The program will help ensure there are more obesity medicine experts to provide care to those in need by offering resources to medical providers interested in becoming American Board of Obesity Medicine (ABOM) certified.
  • The Obesity Medicine Scholarship program, funded by Found, encourages physicians to become ABOM certified.
  • The Obesity Medicine Scholarship program aims to bridge the gap by removing the financial barrier of taking the exam.
  • "Without proper training in obesity medicine, it's easy to overlook the inequities that perpetuate the problem," said Kristal Hartman OAC Chair.

Killer Brownie Company Launches Individually-Wrapped Kitchen Sink Brownies for Distribution to Grocery Stores, C-Stores, Restaurants and More

Retrieved on: 
星期二, 一月 9, 2024
Kitchen sink, Food, Sale, Restaurant, FOMA, Snack, Convenience food

DAYTON, Ohio, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The Killer Brownie Co. ® today announced that its decadent, gourmet Kitchen Sink brownies are now available with individual packaging, designed for wholesale distribution to grocery, convenience stores, food service, restaurants and more.

Key Points: 
  • DAYTON, Ohio, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The Killer Brownie Co. ® today announced that its decadent, gourmet Kitchen Sink brownies are now available with individual packaging, designed for wholesale distribution to grocery, convenience stores, food service, restaurants and more.
  • The Kitchen Sink brownie is mixed with rainbow sprinkles and topped with M&M's® and mini chocolate chips, all baked atop a decadent fudge brownie.
  • For distribution information on the Kitchen Sink blonde brownies, contact [email protected] .
  • According to recent FOMA studies , packaged snacks are a high impulse items for consumers, and 63% are willing to pay more for food and beverage items with recognizable ingredients.

Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss

Retrieved on: 
星期一, 十二月 4, 2023
Health, Telemedicine, Virtual Medicine, Fitness & Nutrition, General Health, Vitamins, Supplements, Pharmaceutical, Topiramate, Metformin, Hims & Hers Health, Sleep, Obesity, Depression, Research, NYSE, FACP, Naltrexone, Major trauma, Medication, Psychology, Gambling, Overweight, Patient, Multimedia, FAAP, Movement, FOMA, Motivation, Weight gain, Digital, Weight loss, MD, CDC, SVP, Heart Health Park, Vitamin B12, Birth control, Nursing, Dietary supplement, Behavior, Hers, Bupropion

View the full release here: https://www.businesswire.com/news/home/20231204073836/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231204073836/en/
    Weight Loss by Hims & Hers (Graphic: Business Wire)
    The science-backed Weight Loss by Hims & Hers program is developed with the expert insight of Dr. Primack and a team of clinical experts in obesity medicine, psychology and nutrition.
  • The program offers a well-rounded and more affordable approach to reducing weight by addressing the underlying factors that affect people’s weight – Nutrition, Behavior, Movement and Medical Treatment.
  • Weight Loss by Hims & Hers aims to address these issues by taking on the physical and psychological factors that contribute to weight gain and loss.
  • For more information on Hims & Hers’ weight loss program, please visit https://www.forhers.com/weight-loss and https://www.hims.com/c/wm/introduction .

Country's Leading Obesity Care Organizations Develop Consensus Statement on Obesity

Retrieved on: 
星期二, 一月 31, 2023
Education, Health, ASMBS, CDN, Academy of Nutrition and Dietetics, Dignity, Policy, Behavior, Cancer, The Obesity Society, Disease, BMI, MD, OAC, Government, Nutrition, Social stigma of obesity, Endoscopy, Diabetes, Bariatric surgery, FACS, FOMA, Patient, Bias, Research, Science, Conditional sentence, MBA, Stigma, Metabolism, Obesity, Body mass index, Organization, Workplace, OMA, Society, Adipose tissue, RDN, CNAME record, Food, Shame, Physician, Fitch, Human, FACP, Quality of life, Risk, Social stigma, Meat, Convenience food, Dentistry, Fast food, Nursing, Birth control, Dietitian

ROCKVILLE, Md., Jan. 31, 2023 /PRNewswire/ -- Six U.S. organizations dedicated to the prevention and treatment of obesity collaborated to develop a consensus statement on obesity, a complex, chronic disease that impacts nearly 42% of adults and 19% of children and adolescents.

Key Points: 
  • ROCKVILLE, Md., Jan. 31, 2023 /PRNewswire/ -- Six U.S. organizations dedicated to the prevention and treatment of obesity collaborated to develop a consensus statement on obesity, a complex, chronic disease that impacts nearly 42% of adults and 19% of children and adolescents.
  • "Our discussions led us to develop the consensus statement to give us a shared starting point for how we talk about obesity," said Anthony G. Comuzzie, CEO of The Obesity Society, one of the organizations involved in developing the statement.
  • The six organizations are unified in their call to invite other health care organizations, medical institutions, practitioners, and advocates to join this effort by formally adopting the consensus statement and publicly acknowledging obesity as a disease.
  • The Obesity Society is the leading organization of scientists and health professionals devoted to understanding and reversing the epidemic of obesity and its adverse health, economic and societal effects.

FOMA Lifetime Achievement Award Presented to MyCare Medical Osteopath, Dr. Ronald Surowitz - 50 Years of Providing Exceptional Health Care Service to Patients in Florida

Retrieved on: 
星期四, 四月 7, 2022
LinkedIn, Principal, Human, Podiatry, College, Leadership, GTA MyCar, Osteopathy, Emergency medicine, Gastroenterology, Board, Cardiology, List of lifetime achievement awards, Endocrinology, Radiation, Medicine, Health, Pediatrics, Psychiatry, National Board of Osteopathic Medical Examiners, OBGYN, Association, Twitter, Muscle, Physician, Student, Medicare, Facebook, Osteopathic medicine in the United States, FOMA, Executive Committee, Social media, Patient, Railway Executive Committee, Veterinary medicine

JUPITER, Fla., April 7, 2022 /PRNewswire/ -- MyCare Medical happily announced that Ronald Surowitz, D.O., received the 2022 Lifetime Achievement Award presented by the Florida Osteopathic Medical Association (FOMA) during its annual convention held February 25-27 in Fort Lauderdale.

Key Points: 
  • JUPITER, Fla., April 7, 2022 /PRNewswire/ -- MyCare Medical happily announced that Ronald Surowitz, D.O., received the 2022 Lifetime Achievement Award presented by the Florida Osteopathic Medical Association (FOMA) during its annual convention held February 25-27 in Fort Lauderdale.
  • The FOMA Lifetime Achievement Award is presented to an osteopathic physician who has regularly made significant contributions to the osteopathic community in Florida throughout the physician's career.
  • Dr. Surowitz received the award in recognition and appreciation of his lifelong commitment, leadership, and devotion to the osteopathic profession providing singular health care to the citizens of Florida for over five decades.
  • "We are extremely pleased to highlight this award given to Dr. Surowitz, and we join him in celebrating a long, distinguished practice," said MyCare Medical.

Jenny Craig Debuts Max Up, Its Most Complete And Effective Weight Loss Program Ever

Retrieved on: 
星期二, 十二月 28, 2021
Muscle, Metabolism, Quality of life, FOMA, CEO, Nutritionist, U.S. News & World Report, Jenny Craig, Inc., Weight loss, Quality, Light, Program, Health, Education, Drinking water, Harvard Medical School, Review, Curriculum, McGovern Medical School, News, Faculty, Fasting, Burn, MD, Snack, Goal, FACP, Dietary supplement, Management

CARLSBAD, Calif., Dec. 28, 2021 /PRNewswire/ -- Jenny Craig , the leading weight loss and weight management company, today unveils its newest, most complete and effective program yet: Max Up .

Key Points: 
  • CARLSBAD, Calif., Dec. 28, 2021 /PRNewswire/ -- Jenny Craig , the leading weight loss and weight management company, today unveils its newest, most complete and effective program yet: Max Up .
  • Max Up is our very first complete program that's designed not only to maximize weight loss but also positively impact overall quality of life," said David Pastrana, CEO of Jenny Craig.
  • "Without Max Up, I would still be hiding on my couch in my house," said Angela T., Jenny Craig Max Up member.
  • The Jenny Craig program is designed to provide structure and support to help members lose weight and learn how to keep it off.

Jenny Craig Appoints Angela Fitch, MD, FACP, FOMA, As Chair Of Science Advisory Board

Retrieved on: 
星期二, 九月 21, 2021
Goal, Harvard Medical School, The Boston Globe, U.S. News & World Report, Weight loss, McGovern Medical School, Frontiers, Health, News, Alan Howard (nutritionist), Association, CBS News, FACP, CBS, Faculty, American Board of Commissioners for Foreign Missions, CEO, Obesity medicine, University, Program, Growth, Leadership, Science, Technology, Snack, Research, Obesity, University of Cincinnati, Internal medicine, Jenny Craig, Inc., American Board of Obesity Medicine, Women's health, Education, Aerospace Journalist of the Year Awards, FOMA, Soft drink, Management, Fast food

CARLSBAD, Calif., Sept. 21, 2021 /PRNewswire/ -- Jenny Craig , the science-based leader in weight loss, today announces the appointment of Angela Fitch, MD, FACP, FOMA, to chair of its science advisory board.

Key Points: 
  • CARLSBAD, Calif., Sept. 21, 2021 /PRNewswire/ -- Jenny Craig , the science-based leader in weight loss, today announces the appointment of Angela Fitch, MD, FACP, FOMA, to chair of its science advisory board.
  • In her role as chair of Jenny Craig's science advisory board, Dr. Fitch will work closely alongside Jenny Craig's executive leadership team on company innovation, lead future Jenny Craig research studies and oversee the other members of the board.
  • "We're thrilled for Dr. Fitch to join Jenny Craig and add fresh insight to our science advisory board as we continue to collaborate to grow and innovate through technology and our weight loss programs," said David Pastrana, CEO of Jenny Craig.
  • The Jenny Craig program is designed to provide structure and support to help members lose weight and learn how to keep it off.